Hint mode is switched on Switch off
For swift navigation between sections

Sagimet Biosciences
LEI 2549002OT2F8BV0VPD02

PDF download

Choose all Reset all
Download Cancel
Organization name
Sagimet Biosciences Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Sagimet Biosciences Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases such as non-alcoholic steatohepatitis (NASH), acne and various cancers. Sagimet Biosciences serves customers worldwide.

Awards

News

28/05/2026 Sagimet Biosciences: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
12/05/2026 Sagimet Biosciences: Results Of Operations And Financial Condition, Financial Statements And Exhibits
27/04/2026 Sagimet Biosciences: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
27/04/2026 Sagimet Biosciences: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
20/04/2026 Sagimet Biosciences: Departure Of Directors Or Principal Officers; Election Of Directors; Appointment Of Principal Officers, Other Events
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    2549002OT2F8BV0VPD02
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001400118
  • EIN
    20-5991472
Registration is required to get access.